Cancer is not a death sentence. Cancer can be cured, especially if the disease is detected at the earliest stage and this is what raising awareness is based on when it comes to regular check-ups and prevention of the development of the disease.
Breast cancer is the most common malignant disease of women in the developed world, affecting about a million women worldwide every year. The largest number of affected women was registered in the age group between 50 and 64 years old, in which the frequency of this cancer is the highest - making up more than one third of malignant cases (30,3%).
Early detection of tumors is important. Early detection means that patients have a better chance of being cured. When the tumor is small, when it has not metastasized, there are great chances that a woman will emerge victorious from that fight.
When it comes to breast cancer, the statistics provide truly worrying data. Montenegro is one of the countries with a high mortality rate of people suffering from this disease, mostly due to late reporting to the doctor, only when symptoms are felt and the disease has already taken hold. The disease is in its initial stage without symptoms, and the possibilities for cure are the greatest at that time. Thanks to modern medicine and advanced techniques, on average nine out of ten women can be successfully cured at this stage.
In the Consilium Polyclinic, Ass. Dr. Sci. med. Marko Buta. Doctor Buta is an assistant at the Faculty of Medicine, University of Belgrade. He participated in numerous projects, was an exhibitor at a large number of professional meetings. He is also the author and co-author of scientific papers published in domestic and international journals and a member of significant professional associations. The field of scientific interest is surgical oncology.

Dr. Buta is a specialist in breast, thyroid and melanoma cancer.
- 2013 - He completed his professional training at the University Clinic in Essen, Germany under Prof. Martin Walz in the Center for Minimally Invasive Surgery with a special focus on minimally invasive surgery of the thyroid, parathyroid and adrenal glands.
- In 2015, he trained at the Center for Minimally Invasive and Oncological Surgery in Ulm, Germany.
- In 2017, he underwent training in the field of breast cancer surgery in Tokyo and Yokohama, Japan.
- 2017 - completed training and became certified for the use of continuous and intermittent neuromonitoring of the vocal nerve (Prag-Medtronic) in thyroid surgery.
Schedule an inspection at: 020/650-660; 067/650-670
Polyclinic Konzilium, Skadarska 2
